mhurhangee/patent-ind-claim-en huggingface dataset:
A medical system for endovascular device placement comprising: a placement unit including a signal acquisition module and an electrode for acquiring ivECG signal data; a multiscale complexity analysis module including software programmed for processing the ivECG signal data acquired by the signal acquisition module using multiscale complexity analysis and determining at least one PxI value; a device configured to provide an audio and/or visual indication of PxI and/or the proximity of the endovascular device to a part of a patient's body; an audio and/or visual notification module programmed to signal the device to provide the user with an audio and/or visual indication of PxI and/or the proximity of the endovascular device to the part of the patient's body, wherein PxI is a density of a tail distribution function. a placement unit including a signal acquisition module and an electrode for acquiring ivECG signal data; a multiscale complexity analysis module including software programmed for processing the ivECG signal data acquired by the signal acquisition module using multiscale complexity analysis and determining at least one PxI value; a device configured to provide an audio and/or visual indication of PxI and/or the proximity of the endovascular device to a part of a patient's body; an audio and/or visual notification module programmed to signal the device to provide the user with an audio and/or visual indication of PxI and/or the proximity of the endovascular device to the part of the patient's body, wherein PxI is a density of a tail distribution function.
Organic electroluminescent device comprising cathode, anode and emitting layer, which comprises the following compounds: (A) a matrix compound; and (B) a luminescent organic compound which contains no metals and which has a separation between the lowest triplet state T 1 and the first excited singlet state S 1 of ≤ 0.15 eV (TADF compound), where the TADF compound is present in the emitting layer in a doping concentration of 10 to 15% by vol. and where the doping concentration of the TADF compound of 10% by vol. in the emitting layer is excluded, characterised in that the matrix compound is an electron-transporting compound selected from the substance classes of the triazines, the pyrimidines, the lactams and the quinoxalines. (A) a matrix compound; and (B) a luminescent organic compound which contains no metals and which has a separation between the lowest triplet state T 1 and the first excited singlet state S 1 of ≤ 0.15 eV (TADF compound),
A grommet comprising: a tapered barrel part including a large diameter cylindrical portion , a small diameter cylindrical portion , and an elastic deformation portion disposed between the large diameter cylindrical portion and the small diameter cylindrical portion ; wherein a fitting groove to be fitted in a through hole (H) of a panel (P), is formed on the large diameter cylindrical portion , and wherein a thick walled portion is formed on an inner surface of the elastic deformation portion ; and a tape winding spatula part connected to the small diameter cylindrical portion and holding a wire harness (W) passed through therein. a tapered barrel part including a large diameter cylindrical portion , a small diameter cylindrical portion , and an elastic deformation portion disposed between the large diameter cylindrical portion and the small diameter cylindrical portion ; wherein a fitting groove to be fitted in a through hole (H) of a panel (P), is formed on the large diameter cylindrical portion , and wherein a thick walled portion is formed on an inner surface of the elastic deformation portion ; and a tape winding spatula part connected to the small diameter cylindrical portion and holding a wire harness (W) passed through therein.
A method of alerting a vehicle operator to a microsleep event, the method comprising: - determining a plurality of eye openness factors by measuring a plurality of distances between an upper eyelid and a lower eyelid of at least one eye over a time period; - generating graphical representations of the eye openness factors; - correlating changes in the eye openness factors over the time period with a reference eye closure pattern indicative of the microsleep event; and - triggering an alarm so as to alert the operator when the eye openness factors, compared to the reference eye closure pattern, are indicative of the microsleep event. - determining a plurality of eye openness factors by measuring a plurality of distances between an upper eyelid and a lower eyelid of at least one eye over a time period; - generating graphical representations of the eye openness factors; - correlating changes in the eye openness factors over the time period with a reference eye closure pattern indicative of the microsleep event; and - triggering an alarm so as to alert the operator when the eye openness factors, compared to the reference eye closure pattern, are indicative of the microsleep event.
A dressing for treating a tissue site comprising: a manifold including a biocompatible material having a plurality of flow channels configured to distribute reduced pressure to the tissue site; and a drape comprising an adhesive layer formed of silicone having a thickness of between 80 and 600 microns, the adhesive layer having a first surface and a second surface, a plasma layer having a thickness of between 5 microns and 15 microns formed by treating the first surface of the adhesive layer with a plasma treatment process, and wherein the second surface of the adhesive layer is configured to adhere at least to the tissue site and cover the biocompatible material to create a sealed space over the biocompatible material within the tissue site. a manifold including a biocompatible material having a plurality of flow channels configured to distribute reduced pressure to the tissue site; and a drape comprising an adhesive layer formed of silicone having a thickness of between 80 and 600 microns, the adhesive layer having a first surface and a second surface, a plasma layer having a thickness of between 5 microns and 15 microns formed by treating the first surface of the adhesive layer with a plasma treatment process, and wherein the second surface of the adhesive layer is configured to adhere at least to the tissue site and cover the biocompatible material to create a sealed space over the biocompatible material within the tissue site. an adhesive layer formed of silicone having a thickness of between 80 and 600 microns, the adhesive layer having a first surface and a second surface, a plasma layer having a thickness of between 5 microns and 15 microns formed by treating the first surface of the adhesive layer with a plasma treatment process, and wherein the second surface of the adhesive layer is configured to adhere at least to the tissue site and cover the biocompatible material to create a sealed space over the biocompatible material within the tissue site.
A method for producing microparticles from a pressurized and heated raw material solution, the method is to prepare a raw material solution having a raw material dissolved in a solvent, which is followed by carrying out a crystallization operation by means of a poor solvent method using the raw material solution thereby obtaining microparticles of the raw material, characterized in that at a time when the raw material solution is prepared, using at least any one of curcumin and γ-oryzanol as the raw material, and using ethanol as the solvent, and a stirring operation is carried out under a pressurized state and a temperature condition of 78.3°C or higher and 130°C or lower. the method is to prepare a raw material solution having a raw material dissolved in a solvent, which is followed by carrying out a crystallization operation by means of a poor solvent method using the raw material solution thereby obtaining microparticles of the raw material, characterized in that at a time when the raw material solution is prepared, using at least any one of curcumin and γ-oryzanol as the raw material, and using ethanol as the solvent, and a stirring operation is carried out under a pressurized state and a temperature condition of 78.3°C or higher and 130°C or lower.
Method of beam shape adjustment and beam profile rotation within a laser processing process, • in which a laser beam in a laser processing apparatus is focused on the surface of a component by means of deflection mirrors and lens systems , • at least one beam shaping module is used to adjust the laser beam in terms of its intensity distribution to the surface of the component to be processed, • during the processing the laser beam is rotated in respect of its orientation by means of a beam profile-rotating optical unit , • the beam shape and the rotation of the beam profile of the laser beam are adjusted depending both on the area of the component to be processed and on the feed vector of the processing speed, and • the beam shape adjustment of the laser beam is implemented by means of a spatial light modulator unit in the beam shaping module , wherein • the beam profile rotation is set by means of counterrotating dove prisms and/or cylindrical lens telescopes . • in which a laser beam in a laser processing apparatus is focused on the surface of a component by means of deflection mirrors and lens systems , • at least one beam shaping module is used to adjust the laser beam in terms of its intensity distribution to the surface of the component to be processed, • during the processing the laser beam is rotated in respect of its orientation by means of a beam profile-rotating optical unit , • the beam shape and the rotation of the beam profile of the laser beam are adjusted depending both on the area of the component to be processed and on the feed vector of the processing speed, and • the beam shape adjustment of the laser beam is implemented by means of a spatial light modulator unit in the beam shaping module , • the beam profile rotation is set by means of counterrotating dove prisms and/or cylindrical lens telescopes .
Double-walled pipe with integrated heating capability for an aircraft or spacecraft , comprising: a pipe body being rigidly formed in one piece from plastic with an inner wall , with an outer wall and with a plurality of wall supports , the wall supports connecting the inner wall to the outer wall , the inner wall and the outer wall defining an intermediate space ; and an electrically conductive coating surrounding the inner wall within the intermediate space and being configured to heat up under application of an electric current such that heat is transferred to the inner wall , wherein the electrically conductive coating has a positive temperature coefficient (PTC). a pipe body being rigidly formed in one piece from plastic with an inner wall , with an outer wall and with a plurality of wall supports , the wall supports connecting the inner wall to the outer wall , the inner wall and the outer wall defining an intermediate space ; and an electrically conductive coating surrounding the inner wall within the intermediate space and being configured to heat up under application of an electric current such that heat is transferred to the inner wall , wherein the electrically conductive coating has a positive temperature coefficient (PTC).
A blowing system comprising an additive manufacturing build chamber , an entry chamber , an entry line , an exit chamber , said blowing chamber enabling to remove gasses created during the melting and sintering procedures from the manufacturing area with the help of a gas flow created between said entry chamber which is fed by said entry line and which has a perforated front plate on a blowing port and a rear plate to which the entry line is connected, and said exit chamber which has an absorption port and which is positioned against the entry chamber in a cabin of said build chamber ; wherein the entry chamber comprises at least one front plate having at least two tiers (c) of said perforations which are positioned on said blowing port side, which have variable diameters as per the chamber axis (x) and which are parallel to the manufacturing area; and characterized in that the exit chamber comprises at least one protrusion which is at the top part of the absorption port and formed so as to extend outwards from the absorption port , which enables the gasses to be delivered to the exit chamber without them being circulated in the cabin .
Aqueous polymeric dispersion, wherein it comprises emulsion polymerization polymeric particles having a monomeric composition comprising at least one monomer selected from acrylic and vinylic monomers and further comprising a mixture of surfactants comprising : a) a phosphate surfactant selected from alkoxylated alkyl phosphate ester acids or salts, preferably alkoxylated alkyl phosphate monoester-diacids or salts or from alkoxylated alkyl diphosphate diester-monoacids or salts or a mixture of alkoxylated alkyl phosphate monoester-diacids or salts and alkoxylated alkyl diphosphate diester-monoacids or salts and at least one of the following surfactants : b) a surfactant selected from alkoxylated alcohol sulfate metal M salts c) a surfactant selected from C 4 -C 18 dialkyl diesters and/or C 4 -C 18 mono alkyl esters of sulfonated C 4 -C 8 dicarboxylic acid metal M salts wherein the polymer of said polymeric particles has a glass transition temperature Tg, as determined by DSC at a second passage at a heat rate of 20°C/min, which is lower than 0°C; and the polymeric particles comprise at least 50% w/w of monomeric units from an acrylic alkyl ester with an alkyl in C 4 -C 10 . a) a phosphate surfactant selected from alkoxylated alkyl phosphate ester acids or salts, preferably alkoxylated alkyl phosphate monoester-diacids or salts or from alkoxylated alkyl diphosphate diester-monoacids or salts or a mixture of alkoxylated alkyl phosphate monoester-diacids or salts and alkoxylated alkyl diphosphate diester-monoacids or salts b) a surfactant selected from alkoxylated alcohol sulfate metal M salts c) a surfactant selected from C 4 -C 18 dialkyl diesters and/or C 4 -C 18 mono alkyl esters of sulfonated C 4 -C 8 dicarboxylic acid metal M salts
A device, comprising: a solar panel frame forming a closed perimeter that is capable of surrounding and supporting an active element of a solar PV panel ,the solar panel frame comprises a frame face that forms an outside perimeter of the solar panel frame, a return flange extending inward from a bottom end of the frame face, a detent riser extending upward from an end of the return flange, characterised by a first detent extending inward and downward into the frame face toward the detent riser, and a second detent that extends downward from the detent riser toward the frame face, wherein the first detent is suitable for being engaged and secured by a first hook end of a panel attachment bracket , and the second detent is suitable for being engaged and secured by a second hook end of a panel attachment bracket. a solar panel frame forming a closed perimeter that is capable of surrounding and supporting an active element of a solar PV panel ,the solar panel frame comprises a frame face that forms an outside perimeter of the solar panel frame, a return flange extending inward from a bottom end of the frame face, a detent riser extending upward from an end of the return flange, characterised by a first detent extending inward and downward into the frame face toward the detent riser, and a second detent that extends downward from the detent riser toward the frame face, wherein the first detent is suitable for being engaged and secured by a first hook end of a panel attachment bracket , and the second detent is suitable for being engaged and secured by a second hook end of a panel attachment bracket.
Gate valve, in particular for an automatic transmission of a motor vehicle, comprising a valve housing which accommodates a guide element in which an axially movable valve gate is arranged, and the valve housing comprises at least one pressure connection and a tank connection axially spaced therefrom and a working connection , wherein at least one pressure connection opening connected to the pressure connection and a tank connection opening axially spaced therefrom and connected to the tank connection and a working connection opening axially arranged between the pressure connection opening and the tank connection opening and connected to the working connection are present on the guide element , wherein a channel that in regions extends axially is present in the valve housing and connects the working connection opening to the working connection , wherein the channel comprises at least one axially extending partial channel which is offset by 90° in the circumferential direction with respect to the pressure connection and/or the tank connection , wherein the axial partial channel has, at least in portions, an approximately circular-segment-shaped or sickle-shaped cross-section, wherein the channel is bounded radially inwardly by the outer wall of the guide element and radially outwardly by an inner wall of the valve housing , wherein the outer wall of the guide element consists of metal, and wherein the valve housing and also its inner wall consists of plastic, which surrounds the guide element , characterised in that the guide element is not completely encapsulated by the plastic material of the valve housing , but rather the front region of the guide element facing the working connection is free, wherein the metal end of the guide element facing the working connection is kept free from the plastic material of the valve housing and a support cap is fixedly arranged thereon, on the base of which a return spring acting on the valve gate is supported.
A compound of following general formula (II): or a pharmaceutically acceptable salt and/or solvate thereof, wherein: • X is a (C 1 -C 10 )alkyl group; • R' 1 to R' 3 are, independently of one another, hydrogen atom, halo, -OR' 9 , -R' 10 OR' 11 , -SR' 12 , -COSR' 13 , -NR' 14 R' 15 , -COR' 16 , -COOR' 17 or a (C 1 -C 6 )alkyl group; • R' 4 to R' 6 are, independently of one another, hydrogen atom, halo, -OR' 18 , - R' 19 OR' 20 , -SR' 21 or -NR' 22 R' 23 ; • R' 7 and R' 8 are, independently of one another, hydrogen atom or a (C 1 -C 10 )alkyl group, or R' 7 and R' 8 form together with the nitrogen atom to which they are chemically linked, an heterocycle; • R' 9 to R' 23 are, independently of one another, hydrogen atom, halo or a group selected from (C 1 -C 6 )alkyl, aryl, (C 1 -C 6 )alkylaryl group for use in the prevention and/or the treatment of disorders associated to the human herpesvirus 8 (HHV8). • X is a (C 1 -C 10 )alkyl group; • R' 1 to R' 3 are, independently of one another, hydrogen atom, halo, -OR' 9 , -R' 10 OR' 11 , -SR' 12 , -COSR' 13 , -NR' 14 R' 15 , -COR' 16 , -COOR' 17 or a (C 1 -C 6 )alkyl group; • R' 4 to R' 6 are, independently of one another, hydrogen atom, halo, -OR' 18 , - R' 19 OR' 20 , -SR' 21 or -NR' 22 R' 23 ; • R' 7 and R' 8 are, independently of one another, hydrogen atom or a (C 1 -C 10 )alkyl group, or R' 7 and R' 8 form together with the nitrogen atom to which they are chemically linked, an heterocycle; • R' 9 to R' 23 are, independently of one another, hydrogen atom, halo or a group selected from (C 1 -C 6 )alkyl, aryl, (C 1 -C 6 )alkylaryl group
OLED device comprising an organic layer which emits light (L 1 ) in operation and which is positioned between an essentially transparent anode layer and an essentially opaque cathode layer , which cathode layer is deliberately structured along a main extension plane (EP) of the OLED device to comprise at least one cathode region in which the cathode layer is present and a plurality of cathode-free regions , through which cathode-free regions visible light (L 2 ) can pass in the direction of a cross extension (CE) of the OLED device, wherein the plurality of cathode-free regions comprise a repetitive pattern (P, P 1 , P 2 , P 3 ) of cathode-free regions with respect to at least one direction along the main extension plane (EP), wherein the cathode layer is arranged to be electrically contacted in one spot to be operated as a cathode layer, wherein the at least one cathode region comprises first cathode regions and second cathode regions , and the plurality of cathode-free regions comprise first cathode-free regions and second cathode-free regions , characterised in that the second cathode regions are larger in size than the first cathode regions , and the second cathode-free regions are smaller in size than the first cathode-free regions .
Method for mashing of malt and water to produce wort in a single upright tank , comprising the steps: - feeding of fresh malt via a fresh malt inlet to a lower part of the tank , - feeding of mash water via a mash water inlet to an upper part of the tank , - mixing of the fresh malt and the mash water in the tank to produce the wort by conveying malt from the lower part of the tank to the upper part of the tank , - discharge of used malt through an upper used malt outlet , and - discharge of wort from the tank through a lower wort outlet . - feeding of fresh malt via a fresh malt inlet to a lower part of the tank , - feeding of mash water via a mash water inlet to an upper part of the tank , - mixing of the fresh malt and the mash water in the tank to produce the wort by conveying malt from the lower part of the tank to the upper part of the tank , - discharge of used malt through an upper used malt outlet , and - discharge of wort from the tank through a lower wort outlet .
A therapy system for applying electrical signals to a patient's spinal cord region, comprising: a first and a second implantable signal delivery device; and a controller having instructions for directing: first electrical signals to the patient's spinal cord region via the first implantable signal delivery device, wherein the first electrical signals have a first frequency in a first frequency range from 3,000 Hz to 100,000 Hz; and second electrical signals in a second frequency range of up to 1,500 Hz to the patient's spinal cord region via the second implantable signal delivery device,wherein the implantable signal delivery devices are electrically coupled to the controller. a first and a second implantable signal delivery device; and a controller having instructions for directing: first electrical signals to the patient's spinal cord region via the first implantable signal delivery device, wherein the first electrical signals have a first frequency in a first frequency range from 3,000 Hz to 100,000 Hz; and second electrical signals in a second frequency range of up to 1,500 Hz to the patient's spinal cord region via the second implantable signal delivery device,wherein the implantable signal delivery devices are electrically coupled to the controller.
A method for concentrating a cellulase from spent fermentation broth, the method comprising the sequence of steps: a. providing the cellulase in the spent fermentation broth in a soluble form; b. controlling cellulase solubility by adjusting protein concentration; adjusting the pH value to a pH value selected between pH 3 and 6 to provide and maintain the cellulase in a solid phase, and adding polyethylene glycol to increase the amount of the cellulase in the solid phase; and c. harvesting the cellulase in the solid phase. a. providing the cellulase in the spent fermentation broth in a soluble form; b. controlling cellulase solubility by adjusting protein concentration; adjusting the pH value to a pH value selected between pH 3 and 6 to provide and maintain the cellulase in a solid phase, and adding polyethylene glycol to increase the amount of the cellulase in the solid phase; and c. harvesting the cellulase in the solid phase.